- Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatmentJaime E Hernandez
BioCryst Pharmaceuticals, Durham, NC, USA
Influenza Other Respi Viruses 6:305-8. 2012..Approximately one-third remained untreated. Young children had the lowest rate of neuraminidase-inhibitor treatment during the 2009 pandemic (P < 0·05)...
- Absence of pharmacokinetic interaction between intravenous peramivir and oral oseltamivir or rimantadine in humansGeorge Atiee
ICON Development Solutions, San Antonio, Texas, USA
J Clin Pharmacol 52:1410-9. 2012..The drugs were well tolerated. These results suggest no reason to expect an effect of concomitant administration of oseltamivir or rimantadine on the safety profile of peramivir in patients with influenza...
- Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United StatesJaime E Hernandez
ID Clinical Development, Clinical Pharmacology, and Clinical Development, BioCryst Pharmaceuticals, Durham, NC, USA
Clin Infect Dis 52:695-706. 2011..We describe the clinical characteristics and outcomes of all patients for whom peramivir was requested under the eIND...